Related Experiment Video
Updated: Aug 4, 2025

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
Published on: October 25, 2024
Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use
Beatrice A Chen1, Thomas Kimble, Lisa H Harris
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh/Magee-Womens Research Institute, Pittsburgh, Pennsylvania; the Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia; the Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; and the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, and Medicines360, San Francisco, and the Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California.
Funding Source:
Medicines360. The Sponsor, Medicines360, designed the study and oversaw its conduct, including funding the trial and providing all study product free of charge to participants.
Clinical Trial Registration:
ClinicalTrials.gov, NCT00995150.

